Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant CD39 antibody

This Mouse Monoclonal antibody specifically detects CD39 in IHC. It exhibits reactivity toward Human.
Catalog No. ABIN7861247
$640.46
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 2 to 5 Business Days

Quick Overview for Recombinant CD39 antibody (ABIN7861247)

Target

See all CD39 (ENTPD1) Antibodies
CD39 (ENTPD1) (Ectonucleoside Triphosphate diphosphohydrolase 1 (ENTPD1))

Antibody Type

Recombinant Antibody

Reactivity

  • 117
  • 32
  • 29
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Host

  • 63
  • 50
  • 9
  • 4
  • 1
Mouse

Clonality

  • 84
  • 42
  • 1
Monoclonal

Conjugate

  • 84
  • 7
  • 6
  • 5
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD39 antibody is un-conjugated

Application

  • 46
  • 40
  • 34
  • 23
  • 13
  • 12
  • 9
  • 6
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (IHC)

Clone

RCD39-8682
  • Purpose

    Recombinant CD39 / ENTPD1 (Marker of Tumor-specific T cells) Antibody

    Specificity

    CD39, also known as ectonucleoside triphosphate diphosphohydrolase 1 (ENP1), is an integral membrane glycoprotein that acts as an extracellular nucleotide-hydrolyzing enzyme. CD39 inhibits ADP-induced platelet aggregation by hydrolyzing ADP to AMP, and ultimately generating Adenosine. Intracellular CD39 undergoes glycosylation at six N-glycosylation sites and translocates to the membrane in order to be an active enzyme. Alternative splicing gives rise to three CD39 isoforms, vascular, placenta I and placenta II. The placenta I isoform differs at the amino terminus whereas the placenta II isoform is missing amino acids 300-510 at the C-terminus. CD39 is expressed in vascular tissues including placenta, lung, skeletal muscle and kidney, as well as endothelium, smooth muscle, cardiac cells, lymphocytes, such as activated B cells, activated NK cells, macrophages, Dendridic cells and platelets. CD39 may be used as an anti-thrombic agent for pre-treating patients at risk for coronary artery occlusion and thrombic stroke.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant full-length human CD39 protein

    Isotype

    IgG1, kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Target

    CD39 (ENTPD1) (Ectonucleoside Triphosphate diphosphohydrolase 1 (ENTPD1))

    Alternative Name

    CD39

    Background

    ATPDase, DKFZp686D194, DKFZp686I093, Ecto apyrase, Ecto ATP diphosphohydrolase, Ectonucleoside triphosphate diphosphohydrolase 1, ENTPD1, FLJ40921, FLJ40959, Lymphoid cell activation antigen, NTPDase 1, SPG64

    Human tonsil or lymph node.

    Molecular Weight

    70-100 kDa

    Gene ID

    953, 576612
You are here:
Chat with us!